These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 34268874)
21. Radiomics Nomogram Building From Multiparametric MRI to Predict Grade in Patients With Glioma: A Cohort Study. Wang Q; Li Q; Mi R; Ye H; Zhang H; Chen B; Li Y; Huang G; Xia J J Magn Reson Imaging; 2019 Mar; 49(3):825-833. PubMed ID: 30260592 [TBL] [Abstract][Full Text] [Related]
22. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Alaminos M; Dávalos V; Ropero S; Setién F; Paz MF; Herranz M; Fraga MF; Mora J; Cheung NK; Gerald WL; Esteller M Cancer Res; 2005 Apr; 65(7):2565-71. PubMed ID: 15805250 [TBL] [Abstract][Full Text] [Related]
23. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics. Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306 [TBL] [Abstract][Full Text] [Related]
24. Single cell RNA sequencing reveals differentiation related genes with drawing implications in predicting prognosis and immunotherapy response in gliomas. Zhou Z; Wei J; Yang Z; Bao Y; Jiang W; Lu B; Wang W; Li L Sci Rep; 2022 Feb; 12(1):1872. PubMed ID: 35115572 [TBL] [Abstract][Full Text] [Related]
25. A Nomogram for Predicting Individual Prognosis of Patients with Low-Grade Glioma. Zhao YY; Chen SH; Hao Z; Zhu HX; Xing ZL; Li MH World Neurosurg; 2019 Oct; 130():e605-e612. PubMed ID: 31319188 [TBL] [Abstract][Full Text] [Related]
26. Whole-Genome Expression Microarray Combined with Machine Learning to Identify Prognostic Biomarkers for High-Grade Glioma. Shu C; Wang Q; Yan X; Wang J J Mol Neurosci; 2018 Apr; 64(4):491-500. PubMed ID: 29502292 [TBL] [Abstract][Full Text] [Related]
27. PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma. Gao YF; Zhu T; Mao CX; Liu ZX; Wang ZB; Mao XY; Li L; Yin JY; Zhou HH; Liu ZQ Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801851 [TBL] [Abstract][Full Text] [Related]
28. Qu S; Liu J; Wang H Front Immunol; 2021; 12():648416. PubMed ID: 33889156 [TBL] [Abstract][Full Text] [Related]
29. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
30. Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction. Qian Z; Li Y; Sun Z; Fan X; Xu K; Wang K; Li S; Zhang Z; Jiang T; Liu X; Wang Y Aging (Albany NY); 2018 Oct; 10(10):2884-2899. PubMed ID: 30362964 [TBL] [Abstract][Full Text] [Related]
31. Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma. Hu X; Martinez-Ledesma E; Zheng S; Kim H; Barthel F; Jiang T; Hess KR; Verhaak RGW Neuro Oncol; 2017 Jun; 19(6):786-795. PubMed ID: 28340142 [TBL] [Abstract][Full Text] [Related]
32. Noninvasive IDH1 mutation estimation based on a quantitative radiomics approach for grade II glioma. Yu J; Shi Z; Lian Y; Li Z; Liu T; Gao Y; Wang Y; Chen L; Mao Y Eur Radiol; 2017 Aug; 27(8):3509-3522. PubMed ID: 28004160 [TBL] [Abstract][Full Text] [Related]
33. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma. Yuan YS; Jin X; Chen L; Liao JM; Zhang Y; Yu KW; Li WK; Cao SW; Huang XZ; Kang CM Front Immunol; 2022; 13():1027794. PubMed ID: 36389690 [TBL] [Abstract][Full Text] [Related]
34. Construction of a novel microRNA-based signature for predicting the prognosis of glioma. Liu G; Rong X; Lin X; Wang H; He L; Peng Y Int J Neurosci; 2023 Dec; 133(8):840-850. PubMed ID: 35353669 [No Abstract] [Full Text] [Related]
35. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study. Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733 [TBL] [Abstract][Full Text] [Related]
36. Identification of a nomogram predicting overall survival based on ADAP2-related apoptosis genes in gliomas. Zhang C; Wang J; Niu Z; Zhang K; Wang C; Wang S; Hou S; Yu D; Lin N Int Immunopharmacol; 2024 Dec; 142(Pt A):113084. PubMed ID: 39243555 [TBL] [Abstract][Full Text] [Related]
37. Conventional MR-based Preoperative Nomograms for Prediction of IDH/1p19q Subtype in Low-Grade Glioma. Liu Z; Zhang T; Jiang H; Xu W; Zhang J Acad Radiol; 2019 Aug; 26(8):1062-1070. PubMed ID: 30393056 [TBL] [Abstract][Full Text] [Related]
38. Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes. Hu Z; Zhang H; Fan F; Wang Z; Xu J; Huang Y; Dai Z; Cao H; Zhang X; Liu Z; Cheng Q Front Immunol; 2021; 12():737650. PubMed ID: 34804019 [TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related]
40. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses. Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]